One important observation here is the reduced immune infiltrates in Redox tumors, which suggests that NFE2L2/KEAP1 signaling may lead to tumor evasion of immune surveillance programs (Supplementary Fig. 10). The gene discussed is KEAP1; the disease is neoplasm.